WebChlamydia trachomatis / Neisseria gonorrhoeae DNA, SDA Test code (s) 17305 Question 1. Which specimen types are suitable for C trachomatis and N gonorrhoeae nucleic acid … WebChlamydia trachomatis, Miscellaneous Sites, Nucleic Acid Amplification, Varies Useful For Detecting Chlamydia trachomatis in non- US Food and Drug Administration -approved specimen types This test is not intended for use in medico-legal applications. This test is not useful for the detection of Chlamydia pneumoniae or other Chlamydia species
Chlamydia/Neisseria gonorrhoeae RNA, TMA with Reflex to …
WebSep 21, 2024 · Conclusion Most RNA- or DNA-positive results after treatment of urogenital C. trachomatis may be caused by non-viable molecular remnants since they cannot be confirmed by culture. In a minority viable C. trachomatis was found in culture at the second visit, indicating that patients may remain infectious at least 7 days after treatment. WebA combined assay for simultaneous detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is used. Individual CT and NG test options are not … ips headspace program
Chlamydia (genus) - Wikipedia
WebChlamydia trachomatis / Neisseria gonorrhoeae DNA, SDA Test code (s) 17305 Question 1. Which specimen types are suitable for C trachomatis and N gonorrhoeae nucleic acid amplification tests (NAATs)? Question 2. Are samples other than genital samples, such as throat and rectal swabs, acceptable for C trachomatis and N gonorrhoeae NAATs? … WebAMP CT uses transcription-mediated amplification (TMA) and hybridization protection assay procedures to qualitatively detect C. trachomatis by targeting a 23S rRNA. Discrepant … WebTrichomonas vaginalis RNA, Qualitative, TMA Patient Preparation Urine: Patient should not have urinated within one hour prior to collection. Female patients should not cleanse the labial area prior to providing the specimen. Methodology Transcription-Mediated Amplification (TMA) Reference Range (s) Alternative Name (s) ips health \\u0026 life